Rapid Micro Biosystems, Inc. ( RPID ) NASDAQ Global Select

Cena: 3.38 ( -2.59% )

Aktualizacja 07-10 21:58
NASDAQ Global Select
Branża: Medical - Devices
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Devices
Zatrudnienie: 193
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 49%
Ilość akcji: 37 099 600
Debiut giełdowy: 2021-07-15
WWW: https://www.rapidmicrobio.com
CEO: Mr. Robert G. Spignesi Jr.
Adres: 1001 Pawtucket Boulevard West
Siedziba: 01854 Lowell
ISIN: US75340L1044
Opis firmy:

Rapid Micro Biosystems, Inc., firma zajmująca się technologią nauk przyrodniczych, zapewnia produkty do wykrywania zanieczyszczenia mikrobiologicznego w produkcji urządzeń farmaceutycznych, medycznych i produktów do higieny osobistej w Ameryce Północnej, Europie i Azji. Firma oferuje platformę Divement Direct, która obejmuje Bezpośredni system, zastrzeżone materiały eksploatacyjne, oprogramowanie do połączenia systemu zarządzania informacjami laboratoryjnymi oraz kompleksowe usługi obsługi klienta i walidacji. Jego platforma automatyzuje i modernizuje ręczne mikrobiologiczne kontrola jakości (MQC) w zakresie pracy dla metod terapeutycznych, takich jak biologiczne, szczepionki, terapie komórkowe i genowe oraz sterylne zastrzyki. Firma zapewnia również instalację i weryfikację, szkolenia techniczne i usługi wsparcia. Jego roztwory są wykorzystywane w monitorowaniu środowiska, testowaniu wody, bioborduku i zastosowaniach testowania uwalniania sterylności. Firma była wcześniej znana jako Genomic Profiling Systems, Inc. i zmieniła nazwę na Rapid Micro Biosystems, Inc. w styczniu 2007 r. Rapid Micro Biosystems, Inc. został włączony w 2006 roku i ma siedzibę w Lowell, Massachusetts.

Wskaźniki finansowe
Kapitalizacja (USD) 148 151 149
Aktywa: 105 843 000
Cena: 3.38
Wskaźnik Altman Z-Score: -5.5
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -3.3
Ilość akcji w obrocie: 49%
Średni wolumen: 112 783
Ilość akcji 43 831 701
Wskaźniki finansowe
Przychody TTM 26 170 000
Zobowiązania: 21 470 000
Przedział 52 tyg.: 0.63 - 4.044
Piotroski F-Score: 4
Umiarkowany (średnia jakość finansowa)
EPS: -1.0
P/E branży: 26.8
Beta: 1.079
Raport okresowy: 2025-08-08
WWW: https://www.rapidmicrobio.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Sean M. Wirtjes Chief Financial Officer 701 256 1969
Mr. John J. Addington Wilson Chief Operating Officer 699 966 1968
Ms. Victoria L. Vezina Chief Human Resources Officer 366 362 1968
Mr. Robert G. Spignesi Jr. Chief Executive Officer, President & Director 1 052 720 1970
Ms. Kristine Williams Senior Vice President of Research & Development and Product Management 0 0
James Xu Vice President of Legal & Secretary 0 0
Michael Beaulieu C.F.A. Vice President of Investor Relations & Corporate Communications 0 0
Mr. Michael Wysocki Senior Vice President of Sales & Marketing 0 0
Wiadomości dla Rapid Micro Biosystems, Inc.
Tytuł Treść Źródło Aktualizacja Link
Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Beaulieu - VP, IR and Corporate Communications Rob Spignesi - President and CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias - Stifel Paul Knight - KeyBanc Capital Markets Chad Wiatrowski - TD Cowen Operator Thank you for standing by. My name is RG, and I will be your conference operator today. seekingalpha.com 2025-05-09 18:29:16 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago. zacks.com 2025-05-09 13:20:43 Czytaj oryginał (ang.)
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results LEXINGTON, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2025. globenewswire.com 2025-05-09 11:00:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Announce First Quarter 2025 Financial Results on May 9, 2025 LEXINGTON, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2025 financial results prior to the market open on Friday, May 9, 2025. globenewswire.com 2025-04-24 20:15:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) LEXINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants (i) on March 3, 2025, of 50,000 restricted stock units (“RSUs”) of the Company's Class A common stock (“Common Stock”) as a material inducement to employment of one new employee and (ii) on March 10, 2025, of non-qualified stock options to purchase an aggregate of 250,000 shares of Common Stock (the “Options”) and 174,000 RSUs as a material inducement to employment to two new employees. All such equity awards were made under the Company's Inducement Plan, as amended (the “Inducement Plan”) and were approved by a majority of the independent directors of the Board of Directors or a duly authorized committee thereof in accordance with Nasdaq Listing Rule 5635(c)(4). The equity awards are subject to the terms and conditions of the Inducement Plan, and the terms and conditions of the applicable stock option and RSU award agreements covering the grants. globenewswire.com 2025-03-12 18:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q4 2024 Earnings Conference Call February 28, 2025 8:00 AM ET Company Participants Mike Beaulieu – Vice President, Investor Relations and Corporate Communications Rob Spignesi – President and Chief Executive Officer Sean Wirtjes – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Paul Knight – KeyBanc Brendan Smith – TD Cowen Operator Thank you for standing by. My name is Eloisa, and I will be your conference operator today. seekingalpha.com 2025-02-28 12:54:43 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago. zacks.com 2025-02-28 10:41:08 Czytaj oryginał (ang.)
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2024. globenewswire.com 2025-02-28 08:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for collaboration on supply chain efficiencies, services, and joint product development. Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for collaboration on supply chain efficiencies, services, and joint product development. globenewswire.com 2025-02-27 18:15:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences. globenewswire.com 2025-02-26 18:15:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025 LEXINGTON, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2024 financial results prior to the market open on Friday, February 28, 2025. globenewswire.com 2025-02-20 18:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenue LEXINGTON, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced preliminary unaudited fourth quarter and full year 2024 revenue. globenewswire.com 2025-01-14 18:15:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Present at 43ʳᵈ Annual J.P. Morgan Healthcare Conference LEXINGTON, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference. globenewswire.com 2025-01-07 18:05:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Participate in the Stifel 2024 Healthcare Conference LEXINGTON, Mass., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Stifel 2024 Healthcare Conference. globenewswire.com 2024-11-08 10:00:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Q3 2024 Earnings Call Transcript Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q3 2024 Results Conference Call November 1, 2024 9:00 AM ET Company Participants Michael Beaulieu - CFA, VP, IR & Corporate Communications Robert Spignesi - President & CEO Sean Wirtjes - CFO Conference Call Participants Brendan Smith - TD Cowen Dan Arias - Stifel Operator Thank you for standing by. My name is Novi, and I will be your conference operator today. seekingalpha.com 2024-11-01 14:45:22 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.31 per share a year ago. zacks.com 2024-11-01 11:10:22 Czytaj oryginał (ang.)
Rapid Micro Biosystems Reports Third Quarter 2024 Financial Results LEXINGTON, Mass., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the third quarter ended September 30, 2024. globenewswire.com 2024-11-01 09:00:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Announce Third Quarter 2024 Financial Results on November 1, 2024 LEXINGTON, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2024 financial results prior to the market open on Friday, November 1, 2024. globenewswire.com 2024-10-23 20:45:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference LEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, September 6, 2024, in New York City. globenewswire.com 2024-09-03 20:50:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.33 per share a year ago. zacks.com 2024-08-02 13:11:49 Czytaj oryginał (ang.)
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results LEXINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the second quarter ended June 30, 2024. globenewswire.com 2024-08-02 11:00:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024 LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2024 financial results prior to the market open on Friday, August 2, 2024. globenewswire.com 2024-07-17 20:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.32 per share a year ago. zacks.com 2024-05-03 13:10:16 Czytaj oryginał (ang.)
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results Reports first quarter 2024 total revenue of $5.6 million , representing growth of 11% compared to first quarter 2023 globenewswire.com 2024-05-03 11:00:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024 LOWELL, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release first quarter 2024 financial results prior to the market open on Friday, May 3, 2024. globenewswire.com 2024-04-18 20:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024 Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application Company to give technical presentation on its innovative Growth Direct® Rapid Sterility Application globenewswire.com 2024-03-19 18:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the virtual KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024. globenewswire.com 2024-03-12 18:50:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) LOWELL, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that, effective March 4, 2024, the Compensation Committee of the Company's Board of Directors granted non-qualified stock options to purchase 150,000 shares of the Company's Class A common stock (“Common Stock”) and 75,000 restricted stock units (“RSUs”) to a new employee under the Company's 2023 Inducement Plan, as amended (the “2023 Inducement Plan”). globenewswire.com 2024-03-06 20:40:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript seekingalpha.com 2024-03-01 15:31:09 Czytaj oryginał (ang.)
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance Reports fourth quarter 2023 total revenue of $6.3 million , representing 45% growth compared to fourth quarter 2022 globenewswire.com 2024-03-01 08:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences LOWELL, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the following investor conferences: globenewswire.com 2024-02-27 18:30:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024 LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2023 financial results prior to the market open on Friday, March 1, 2024. globenewswire.com 2024-02-20 18:36:00 Czytaj oryginał (ang.)
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company's fully automated Growth Direct system and delivers time to organism detection in as little as 12 hours and final time-to-result in as little as one to three days globenewswire.com 2024-01-10 09:22:00 Czytaj oryginał (ang.)